Stay updated on Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check7 days agoChange DetectedA sitewide notice appears announcing NIH’s website transition and explaining that “Super Intelligence” may be used in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now identifies site release v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check21 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check28 days agoChange DetectedThe study record history page appears unchanged, with the same version table and study details visible.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history, and the previous revision (v3.6.6) was removed from the list. This reflects an update to the revision history itself, aligning with the latest version of the record.SummaryDifference0.1%

Stay in the know with updates to Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page.